Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
31 /100
MEDIUM RISK
Score updated Oct 13, 2026

MLTX — MoonLake Immunotherapeutics Dilution Risk Tracker

Track MLTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MLTX — Get alerts when the score changes →

As of October 13, 2026, MoonLake Immunotherapeutics (MLTX) has a DilutionWatch DilutionScore of 31/100, rated MEDIUM dilution risk. MoonLake Immunotherapeutics has a market capitalization of $908.94M, 85.11M shares outstanding, 150 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
0
📊 Float Risk
50
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for MLTX.
🔔 Track MLTX — Get forecast alerts →

Market Data

Market Cap$908.94M
Shares Outstanding85.11M
Float38.25M
Cash$477.90M
Debt$99.51M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore31/100DilutionWatch score record
Shares Outstanding85.11MVerified float table or market cache
Public Float38.25MVerified float table or market cache
Market Cap$908.94MMarket data cache
Cash Runway44.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 19.4% shares (2026Q1 vs prior)
150 institutional holders · 71.93M shares
#1 BVF INC/IL 16.00M shares
#2 JANUS HENDERSON GROUP PLC 6.90M shares
#3 Deep Track Capital, LP 6.41M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest8.05M
Days to Cover4.2
% of Float21.0%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-02-26
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual MLTX Dilution Snapshot

MoonLake Immunotherapeutics (MLTX) has a DilutionScore of 31/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

MLTX's DilutionScore is currently 31/100 (Medium risk), with 2 score changes tracked over 89 days. The score improved from 30/100 (Medium risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202631/100MEDIUM14 days
Aug 22 – Sep 29, 202630/100MEDIUM39 days
Jul 16 – Aug 21, 202633/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

MLTX shares outstanding have increased 2.6% from 71.73M (Apr 2026) to 73.62M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 29, 202673.62M38.25M▼ 4.04%
May 13, 202673.62M39.86M▲ 0.57%
May 03, 202672.85M39.64M▲ 0.44%
Apr 17, 202671.73M39.46M▲ 0.38%
Apr 13, 202671.73M39.31M▲ 0.22%
Apr 07, 202671.73M39.23M▲ 10.57%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track MLTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment MLTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking MLTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MLTX
MLTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.